Diabetes Devices Market Size & Share, by Type (Blood Glucose Monitoring, Insulin Delivery Devices); Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Clinics, Online Pharmacy); End-user (Diagnostic Center, Hospitals, Home Care) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

Request Free Sample Copy

Report ID: 4642
Published Date: Jan 30, 2023
Report Format: PDF, PPT

Buy Now

Companies Dominating the Diabetes Devices Landscape

Medtronic plc
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Abbott Laboratories
ARKRAY, Inc.
Bayer AG
Lifescan, Inc.
B. Braun Melsungen AG
Dexcom, Inc.
Insulet Corporation
Ypsomed AG
Sanofi

Browse Key Market Insights with Data Illustration:

Diabetes Devices Market Size & Share, Forecast Report 2033

In the News

LifeScan IP Holdings, LLC declared the launch of U.S OneTouch Verio Reflect, the first product with a Blood Sugar Mentor. This feature allows people with diabetes a personalized real-time guide.
Insulet Corporation declared that it’s Omnipod 5 Automated Insulin Delivery System received clearance from the U.S Food and Drug Administration. This was used for 6 years and older people suffering from type 1 diabetes.

Frequently Asked Questions (FAQ)

Rising diabetes cases and the growing obese population across the world are the major factors driving the growth of the diabetes devices market.

The market is anticipated to attain a CAGR of ~7% over the forecast period, i.e., 2023 â€“ 2033.

Lack of knowledge to operate devices and the presence of side effects are the challenges affecting the market growth.

The market in North America region is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are Medtronic plc, Abbott Laboratories, Arkray, Inc., Bayer AG, Lifescan, Inc., B. Braun Melsungen AG, Dexcom, Inc., Insulet Corporation, Ypsomed AG, Sanofi.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by type, distribution channel, end-user, and by region.

The insulin delivery devices segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.

Companies Dominating the Diabetes Devices Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What are the major factors driving the growth of the diabetes devices market?

What would be the CAGR of diabetes devices market over the forecast period?

What are the challenges affecting the diabetes devices market growth?

Which region will provide more business opportunities for growth of diabetes devices market in future?

Who are the major players dominating the diabetes devices market?

How are the company profiles selected?

What are the segments in the diabetes devices market?

Which segment captures the largest market size in type in the diabetes devices market?